Screener
Boston Scientific BSX Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Boston Scientific in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: Boston Scientific’s 10-Q, filed May 1, 2026.
- Filed
- May 1, 2026, 6:25 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000885725-26-000033
| (in millions, except share and per share data) | As of / March 31, 2026 | As of / December 31, 2025 |
|---|---|---|
| Goodwill | 18,536 | 18,282 |
| Other intangible assets, net | 7,060 | 7,019 |
| Deferred tax assets | 3,953 | 3,675 |
| Other long-term assets | 2,054 | 1,866 |
| TOTAL ASSETS | $44,351 | $43,673 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities: | ||
| Current debt obligations | $41 | $299 |
ITEM 1. CONSOLIDATED FINANCIAL STATEMENTS
FAQ
- What is Boston Scientific's deferred tax assets and other non-current assets?
- Boston Scientific (BSX) reported deferred tax assets and other non-current assets of $2.05B in Q1 2026.
- How has Boston Scientific's deferred tax assets and other non-current assets changed year-over-year?
- Boston Scientific's deferred tax assets and other non-current assets increased by 12.0% year-over-year, from $1.83B to $2.05B.
- What is the long-term trend for Boston Scientific's deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), Boston Scientific's deferred tax assets and other non-current assets has grown at a -0.6% compound annual growth rate (CAGR), from $1.92B to $1.87B.
Ask your AI about Boston Scientific's deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude